Benzinga

Benzinga

Benzinga

viernes, agosto 28

Matinas BioPharma Holdings Inc

MTNBAMEX
Trade with Public
Trade with Public
$0.2000
N/A
al cierre: Aug 28, 5:00 PM EST
$0.2000
N/A
After hour: 9:26 AM EST
Panorámica generalNoticiasPrevisión de beneficiosPrecios objetivoFinanzasSentimientoPropiedadCompararInforme de acciones

Matinas BioPharma Hldgs Analyst Price Targets

Wall Street analyst price targets and consensus rating for Matinas BioPharma Hldgs (MTNB).

Price Target Range — 1 Quarters

Analyst Consensus — 2 Analysts

1Buy
1Hold
Consensus RatingBuy# Analysts2Avg. Consensus PT$3Upside to Avg. PT+1400.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Oct 31, 2024Maxim GroupJason McCarthyDowngradeBuy→Hold—
Oct 11, 2023BTIGJulian HarrisonReinstatesBuy$3

Analyst Ratings News

PRO
Maxim Group Downgrades Matinas BioPharma Hldgs to Hold

Maxim Group analyst Jason McCarthy downgrades Matinas BioPharma Hldgs (AMEX:MTNB) from Buy to Hold.
Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Matinas BioPharma Hldgs, Maintains $3 Price Target

BTIG analyst Julian Harrison reiterates Matinas BioPharma Hldgs (AMEX:MTNB) with a Buy and maintains $3 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Matinas BioPharma Hldgs, Maintains $3 Price Target

HC Wainwright & Co. analyst Andrew Fein reiterates Matinas BioPharma Hldgs (AMEX:MTNB) with a Buy and maintains $3 price target.
Benzinga Newsdesk

HC Wainwright Reiterates Buy Rating On BioNTech, While Lowers Price Target

HC Wainwright has reiterated its Buy rating on BioNTech SE (NASDAQ: BNTX) while reducing the price tar
Vandana Singh

PRO
Aegis Capital Maintains Buy on Matinas BioPharma Hldgs, Raises Price Target to $3.5

Aegis Capital maintains Matinas BioPharma Hldgs (AMEX:MTNB) with a Buy and raises the price target from $3.25 to $3.5.
Benzinga Newsdesk

Benzinga's Top Upgrades, Downgrades For January 27, 2020

Lisa Levin

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved